EXOZ

Conviction 0HealthcareScan · Mon, Aug 10, 2026

EXOZ$5.11-1.17%

ResistanceSupportVol 14Insider sell

Vol MA14 7.41K

May 8May 27Jun 15Jul 2Jul 22Aug 7

EXOZYMES INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.exozymes.com ↗

Price5.11

Change-1.17%

Gap-0.49%

Rel volume0.36×

Avg volume7.99K

Avg $ vol42.25K

SMA 205.24

SMA 506.98

SMA 2009.65

Price vs 50-26.88%

Price vs 200-47.11%

MA stackbearish

50/200 cross—

Supertrenddown · 6.27

RSI (14)41

MACD hist0.14

MACD crossbull · 3d

Stoch %K / %D46 / 49

ADX (14)39

+DI / −DI18 / 21

RSI divergence—

MACD divergence—

ATR %+11.45%

ADR %10.37%

52w high16.50

52w low0.0000

From 52w high-69.06%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width56.50%

%B0.46

Donchian pos22.78%

Donchian high7.67

Donchian low4.35

AVWAP (52w high)9.11

vs AVWAP high-43.98%

AVWAP (52w low)9.42

vs AVWAP low-45.82%

OBV trendDown

Chaikin MF (20)-0.55

Today vs 20d0.36×

Avg vol (14d)7.41K

Avg vol (20d)7.99K

Avg $ vol (20d)42.25K

Market cap43.29M

RS 3m (vs SPY)-54.65%

RS 6m (vs SPY)-67.06%

RS line new highNo

Trend template0/8

Technical rank9.4

1 week+9.78%

1 month-27.90%

3 months-48.95%

6 months-52.95%

1 year-49.00%

YTD-53.55%

P/E-4.73

P/B28.33

P/S617.75

P/FCF-6.49

EPS-1.09

Div yield—

ROE-599.35%

ROA-227.89%

Debt/Eq—

Current1.32

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-56.26%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value41.84M

Revenue70.77K

Net income-2.37M

Gross profit—

Free cash flow-6.67M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out8.48M

Employees32

ListedWed, Nov 13, 2024

Free float2.52M

Float %29.7%

Short interest19.58K

Days to cover1.0d

Short volume27.6%

Squeeze score7 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank9.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.46

Support4.45

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EXOZ

All disclosures →

No recent disclosed trades by Congress in EXOZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EXOZ · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Korman Tyler Paz Chief Scientific Officer · COMMON STOCK · 2026-04-09	Sell	750	$8K	2026-04-09	2026-04-10
Korman Tyler Paz Chief Scientific Officer · COMMON STOCK · 2026-04-08	Sell	750	$8K	2026-04-08	2026-04-10

SEC filings

EDGAR filings in EXOZ · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.